A new package insert, approved by the FDA, includes information about psoriasis in the genital area.

This new development may increase chances of patients discussing the disease with their doctor — and healthcare professionals being better poised to treat it.

You can read about the study that prompted the update and why it’s important in this Drugs.com article.